PRESS RELEASE published on 10/25/2024 at 07:30, 27 days 3 hours ago Inside Information / Other news releases
BRIEF published on 10/01/2024 at 08:50, 1 month 20 days ago REMY COINTREAU Issues Notice to Bondholders Convertible Bonds Financial Update Rémy Cointreau Bonds Notice ISIN FR0013200995
PRESS RELEASE published on 10/01/2024 at 08:45, 1 month 20 days ago Inside Information / Other news releases REMINDER: Holders of REMY COINTREAU 0.125% bonds (ISIN: FR0013200995) to convert/exchange by 07/09/2026 ISIN Convertible Rémy Cointreau 0.125% Bonds FR0013200995
PRESS RELEASE published on 07/24/2024 at 07:30, 3 months 28 days ago Quarterly financial reporting / First quarter financial report
BRIEF published on 07/17/2024 at 08:39, 4 months 4 days ago REMY COINTREAU Announced Total Voting Rights and Share Capital Information Share Capital Voting Rights Shares AMF Rémy Cointreau
PRESS RELEASE published on 07/17/2024 at 08:34, 4 months 4 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital French Société anonyme with a capital of 82,004,750.40 euros provides information on total voting rights and shares. Code ISIN: FR0000130395 Shares French Société Anonyme AMF Total Voting Rights Code ISIN
BRIEF published on 06/26/2024 at 18:34, 4 months 24 days ago Rémy Cointreau: Availability of the 2023-24 Universal Registration Document Financial Markets Authority Share Buyback Annual Financial Report Universal Registration Document Rémy Cointreau
BRIEF published on 06/12/2024 at 08:45, 5 months 9 days ago Rémy Cointreau: Number of Voting Rights and Shares as of May 31, 2024 Share Capital Voting Rights Actions General Assembly Rémy Cointreau
PRESS RELEASE published on 06/12/2024 at 08:40, 5 months 9 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital French Société anonyme announces total number of shares, exercisable voting rights and theoretical voting rights as of May 31, 2024 Voting Rights Capital Shares French Société Anonyme Financial Markets
BRIEF published on 06/07/2024 at 09:03, 5 months 14 days ago Total Number of Voting Rights and Capital for Rémy Cointreau Share Capital Voting Rights Financial Update Rémy Cointreau Stock Information
Published on 11/21/2024 at 10:03, 43 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 46 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 46 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 11 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 21 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 15 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 41 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 43 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 45 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 45 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 26 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
